Tag: Survival
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
However, disparities exist among cancer survivors by race and health coverage
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
TAR-200 monotherapy was well tolerated, with high complete response rate and prolonged disease-free survival
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo versus sunitinib
Study Offers Comprehensive Evaluation of Survival Parameters for Pediatric CNS Tumors
Highest estimated 10- and 15-year survival rates seen for low-grade gliomas; lowest rates seen for high-grade gliomas excluding gliomas not otherwise specified
Cancer Diagnosis Not Tied to Later Healthier Eating Habits
Eating behaviors similar between cancer survivors, those without cancer
Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome
Low Prognostic Nutritional Index and high systemic oxidative stress score independently associated with poorer prognosis
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
89 percent of 509 patients would have been ineligible for MajesTEC-1 trial; estimated median PFS was 5.8 months
Risk for Severe COVID-19 Elevated for Childhood Cancer Survivors
However, childhood cancer survivors have lower risk for registered COVID-19 infection relative to comparators
Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer
Better posttreatment pathology and similar overall survival seen for stereotactic ablative radiotherapy group despite more advanced disease
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
Introduction of immune checkpoint inhibitors linked to widening disparity for those with private insurance versus those without insurance
